Plasminogen Derivatives Encoding Kringles 1-4 and Kringles 1-5 Exert Indirect Antiangiogenic and Direct Antitumoral Effects in Experimental Lung Cancer

REFERENCES

• Sim B. K., O'Reilly M.S., Liang. H., Fortier A. H., He W., Madsen J. W., et al. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 1997; 57: 1329–1334
   PubMed Web of Science ®Google Scholar
• Cao Y. Therapeutic potentials of angiostatin in the treatment of cancer. Haematologica 1999; 84: 643–650
   PubMedGoogle Scholar
• Yang D. Z., He J., Zhang J. C., Wang Z. R. Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice. World J Gastroenterol 2005; 11: 4992–4996
   PubMed Web of Science ®Google Scholar
• Griscelli F., Li H., Bennaceur-Griscelli A., Soria J., Opolon P., Soria C., et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA 1998; 95(11)6367–6372
   PubMed Web of Science ®Google Scholar
• Gyorffy S., Palmer K., Gauldie J. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice. Am J Pathol 2001; 159(3)1137–1147
   PubMed Web of Science ®Google Scholar
• Indraccolo S., Morini M., Gola E., Carrozzino F., Habeler W., Minghelli S., et al. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells. Cancer Res 2001; 61(14)5441–5446
   PubMed Web of Science ®Google Scholar
• Schmitz V., Wang L., Barajas M., Peng D., Prieto J., Qian C. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen. Gene Ther 2002; 9(23)1600–1606
   PubMed Web of Science ®Google Scholar
• Galaup A., Magnon C., Rouffiac V., Opolon P., Opolon D., Lassau N., et al. Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice. Gene Ther 2005; 12(10)831–842
   PubMed Web of Science ®Google Scholar
• Cao R., Wu H. L., Veitonmaki N., Linden P., Farnebo J., Shi G Y, et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc Natl Acad Sci USA 1999; 96(10)5728–5733
   PubMed Web of Science ®Google Scholar
• Chi S. L., Pizzo S. V. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase. Cancer Res 2006; 66(2)875–882
   PubMed Web of Science ®Google Scholar
• Veitonmaki N., Cao R., Wu L. H., Moser T. L., Li B., Pizzo S. V., et al. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Cancer Res 2004; 64(10)3679–3686
   PubMed Web of Science ®Google Scholar
• Sharma M. R., Rothman V., Tuszynski G. P., Sharma M. C. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action. Exp Mol Pathol 2006
   Web of Science ®Google Scholar
• Magnon C., Galaup A., Mullan B., Rouffiac V., Bouquet C., Bidart J. M., et al. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. Cancer Res 2005; 65(10)4353–4361
   PubMed Web of Science ®Google Scholar
• Nestler G., Schulz H. U., Tautenhahn J., Kuhn R., Kruger S., Lippert H., et al. Effects of the angiogenesis inhibitor angiostatin on the growth of CC531 colon carcinoma cells in vitro and in a laparoscopic animal model of peritoneal carcinomatosis. Int J Colorectal Dis 2006; 21(4)314–320
   PubMed Web of Science ®Google Scholar
• He T. C., Zhou S., da Costa L.T., Yu J., Kinzler K. W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95(5)2509–2514
   PubMed Web of Science ®Google Scholar
• Schmitz V., Raskopf E. Plasminogen fragment K1-5 improves survival in a murine HCC model. Gut 2006
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1–2)55–63
   PubMed Web of Science ®Google Scholar
• O'Reilly M.S., Holmgren L., Chen C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996; 2(6)689–692
   PubMed Web of Science ®Google Scholar
• Cao Y., Ji R. W., Davidson D., Schaller J., Marti D., Sohndel S., et al. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 1996; 271(46)29461–29467
   PubMed Web of Science ®Google Scholar
• Cornelius L. A., Nehring L. C., Harding E., Bolanowski M., Welgus H. G., Kobayashi D. K., et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 1998; 161(12)6845–6852
   PubMed Web of Science ®Google Scholar
• Lucas R., Holmgren L., Garcia I., Jimenez B., Mandriota S. J., Borlat F., et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998; 92(12)4730–4741
   PubMed Web of Science ®Google Scholar
• Hanford H.A., Wong C. A., Kassan H., Cundiff D. L., Chandel N., Underwood S., et al. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells. Cancer Res 2003; 63(14)4275–4280
   PubMed Web of Science ®Google Scholar
• Stack M. S., Gately S., Bafetti L. M., Enghild J. J., Soff GA. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem J 1999; 340(Pt 1)77–84
   PubMedGoogle Scholar
• Chen Y. H., Wu H. L., Li C., Huang Y. H., Chiang C. W., Wu M. P., et al. Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL, AKT and mRNA deregulation. Thromb Haemost 2006; 95(4)668–677
   PubMed Web of Science ®Google Scholar
• Raskopf E., Dzienisowicz C., Hilbert T., Rabe C., Leifeld L., Wernert N., et al. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model. Hepatology 2005; 41(6)1233–1240
   PubMed Web of Science ®Google Scholar